The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 12, 2024
Filed:
Dec. 29, 2020
Applicant:
Aiviva Biopharma, Inc., Las Vegas, NV (US);
Inventors:
Diane Tang-Liu, Las Vegas, NV (US);
Gerald Woodrow DeVries, San Clemente, CA (US);
Assignee:
AIVIVA BIOPHARMA, INC., Las Vegas, NV (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4402 (2006.01); A61K 9/00 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61P 17/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4402 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61P 17/02 (2018.01);
Abstract
A pharmaceutical composition for prevention or treatment of a disease or disorder characterized by chronic inflammation, with associated angiogenesis and fibrosis, wherein the disease or disorder is selected from the group consisting of rosacea, psoriasis, erythema multiforme, bullous pemphigoid, hereditary hemorrhagic telangiectasia, rheumatoid arthritis, atopic dermatitis, and dermal wound healing. The pharmaceutical composition includes at least one multi-kinase inhibitor selected from the group consisting of axitinib, nintedanib, and lenvatinib.